Deutsche Bank upgrades Genzyme (Nasdaq: GENZ) to Buy with a $63 price target, citing valuation after recent share slide.

Deutsche analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE